Cytori Therapeutics, Inc. Announces Promising Results In A Feasibility Trial Of Cytori Cell Therapy In Conjunction With Anterior Cruciate Ligament Repair

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) today reported positive results from a clinical study of Cytori Cell Therapy™ in anterior cruciate ligament (ACL) reconstruction of patients with ACL tears. The 6 month results from the first 20 patients with combination Cytori Cell Therapy and bone-patellar tendon-bone (BPTB) grafts were presented at the Barcelona Knee Symposium on November 20, 2014.

Help employers find you! Check out all the jobs and post your resume.